MILICA MARGETA M.D. PH.D.
Prescription History 1225328321
Ophthalmology in Boston, MA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MILICA MARGETA M.D. PH.D., an active Ophthalmology specialist practicing in Boston, MA. Our medical registry currently tracks 21 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 1,774 documented patient claims. Among these therapy options, the most frequently utilized medication is Latanoprost, which accounts for 592 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other MA PrescribersVs. MA Avg |
|---|---|---|---|
| Latanoprost | 592 | $17.74▼ below MA avg | ▲ More than typical |
About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾ It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA. In 2023, this provider wrote 592 Medicare prescriptions for Latanoprost, about 3.3 times the volume of the typical Massachusetts prescriber of this medication (181). Medicare paid an average of $17.74 per fill, versus $22.08 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 1,023.4 30-Day Fills standardized to 30-day supplies 29,658 Days of Medication total across all patients in 2023 | |||
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 304 | $30.06▼ below MA avg | ▲ More than typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 304 Medicare prescriptions for Dorzolamide-Timolol, about 3 times the volume of the typical Massachusetts prescriber of this medication (101). Medicare paid an average of $30.06 per fill, versus $34.32 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 648.8 30-Day Fills standardized to 30-day supplies 19,451 Days of Medication total across all patients in 2023 | |||
| Timolol Maleate | 213 | $32.88▼ below MA avg | ▲ More than typical |
About Timolol Maleate: This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers. A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor. In 2023, this provider wrote 213 Medicare prescriptions for Timolol Maleate, about 13 times the volume of the typical Massachusetts prescriber of this medication (17). Medicare paid an average of $32.88 per fill, versus $481.44 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 457 30-Day Fills standardized to 30-day supplies 13,544 Days of Medication total across all patients in 2023 | |||
| Brimonidine Tartrate | 190 | $22.02▼ below MA avg | ▲ More than typical |
About Brimonidine Tartrate: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 190 Medicare prescriptions for Brimonidine Tartrate, about 2.3 times the volume of the typical Massachusetts prescriber of this medication (84). Medicare paid an average of $22.02 per fill, versus $49.72 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 377.2 30-Day Fills standardized to 30-day supplies 11,154 Days of Medication total across all patients in 2023 | |||
| RhopressaNetarsudil Mesylate | 85 | $507.75▼ below MA avg | ▲ More than typical |
About Rhopressa: Netarsudil is used to treat high pressure inside the eye due to certain eye conditions (such as open-angle glaucoma, ocular hypertension). Show more ▾ This medication is thought to work by increasing the flow of fluid out of the eye. This helps lower pressure inside the eye. Lowering high pressure inside the eye can help prevent loss of vision or blindness. In 2023, this provider wrote 85 Medicare prescriptions for Rhopressa, about 1.5 times the volume of the typical Massachusetts prescriber of this medication (55). Medicare paid an average of $507.75 per fill, versus $513.90 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 129.4 30-Day Fills standardized to 30-day supplies 3,600 Days of Medication total across all patients in 2023 | |||
| LumiganBimatoprost | 72 | $446.13▼ below MA avg | ≈ Typical |
About Lumigan: Bimatoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol-derived amide that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 72 Medicare prescriptions for Lumigan, about the same volume as the typical Massachusetts prescriber of this medication (68). Medicare paid an average of $446.13 per fill, versus $511.99 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 114.8 30-Day Fills standardized to 30-day supplies 3,219 Days of Medication total across all patients in 2023 | |||
| Alphagan PBrimonidine Tartrate | 51 | $456.23 | ≈ Typical |
About Alphagan P: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 51 Medicare prescriptions for Alphagan P, about 1.2 times the volume of the typical Massachusetts prescriber of this medication (42). Medicare paid an average of $456.23 per fill, versus $437.42 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 102.7 30-Day Fills standardized to 30-day supplies 3,050 Days of Medication total across all patients in 2023 | |||
| TafluprostTafluprost/Pf | 31 | $171.12 | – No State Data |
About Tafluprost: Tafluprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. In 2023, this provider wrote 31 Medicare prescriptions for Tafluprost. Medicare paid an average of $171.12 per fill. No state comparison is available for this medication. How often this provider prescribes it No state benchmark is available for this medication. What Medicare paid per fill $171.12 Cost per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 39 30-Day Fills standardized to 30-day supplies 1,170 Days of Medication total across all patients in 2023 | |||
| Dorzolamide-TimololDorzolamide/Timolol/Pf | 30 | $183.23 | ▼ Less than typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 30 Medicare prescriptions for Dorzolamide-Timolol, about a third of the volume of the typical Massachusetts prescriber of this medication (101). Medicare paid an average of $183.23 per fill, versus $34.32 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 55 30-Day Fills standardized to 30-day supplies 1,650 Days of Medication total across all patients in 2023 | |||
| Travoprost | 28 | $164.29▼ below MA avg | ≈ Typical |
About Travoprost: Travoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol derivative that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 28 Medicare prescriptions for Travoprost, about the same volume as the typical Massachusetts prescriber of this medication (31). Medicare paid an average of $164.29 per fill, versus $280.99 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 49.2 30-Day Fills standardized to 30-day supplies 1,440 Days of Medication total across all patients in 2023 | |||
| Prednisolone Acetate | 25 | $61.74 | ▼ Less than typical |
About Prednisolone Acetate: This medication is used to treat certain eye conditions due to inflammation or injury. Show more ▾ Prednisolone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. In 2023, this provider wrote 25 Medicare prescriptions for Prednisolone Acetate, about 18% of the volume of the typical Massachusetts prescriber of this medication (141). Medicare paid an average of $61.74 per fill, versus $47.61 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 45.2 30-Day Fills standardized to 30-day supplies 1,246 Days of Medication total across all patients in 2023 | |||
| Pilocarpine Hcl | 25 | $62.76▼ below MA avg | ▼ Less than typical |
About Pilocarpine Hcl: This medication is used to treat symptoms of dry mouth due to a certain immune disease (Sjogren's syndrome) or from saliva gland damage due to radiation treatments of the head/neck for cancer. Show more ▾ Pilocarpine belongs to a class of drugs known as cholinergic agonists. It works by stimulating certain nerves to increase the amount of saliva you produce, making it easier and more comfortable to speak and swallow. A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma. In 2023, this provider wrote 25 Medicare prescriptions for Pilocarpine Hcl, about 74% of the volume of the typical Massachusetts prescriber of this medication (34). Medicare paid an average of $62.76 per fill, versus $88.14 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 61.8 30-Day Fills standardized to 30-day supplies 1,854 Days of Medication total across all patients in 2023 | |||
| Ketorolac Tromethamine | 20 | $11.99▼ below MA avg | ▼ Less than typical |
About Ketorolac Tromethamine: This medication is used to temporarily relieve itching eyes caused by seasonal allergies. Show more ▾ It is also used to prevent and treat eye swelling due to a certain type of eye surgery (cataract removal). Ketorolac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). It works by blocking certain natural substances in your body to reduce pain and swelling. A pyrrolizine carboxylic acid derivative structurally related to INDOMETHACIN. It is a non-steroidal anti-inflammatory agent used for analgesia for postoperative pain and inhibits cyclooxygenase activity. In 2023, this provider wrote 20 Medicare prescriptions for Ketorolac Tromethamine, about 18% of the volume of the typical Massachusetts prescriber of this medication (113). Medicare paid an average of $11.99 per fill, versus $23.31 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 23.8 30-Day Fills standardized to 30-day supplies 479 Days of Medication total across all patients in 2023 | |||
| Dorzolamide Hcl | 16 | $26.97▼ below MA avg | ▼ Less than typical |
About Dorzolamide Hcl: Dorzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 16 Medicare prescriptions for Dorzolamide Hcl, about a quarter of the volume of the typical Massachusetts prescriber of this medication (59). Medicare paid an average of $26.97 per fill, versus $34.35 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 40.5 30-Day Fills standardized to 30-day supplies 1,215 Days of Medication total across all patients in 2023 | |||
| RocklatanNetarsudil Mesylat/Latanoprost | 16 | $584.47 | ▼ Less than typical |
About Rocklatan: Netarsudil/latanoprost is used to treat high pressure inside the eye due to certain eye conditions (such as open-angle glaucoma, ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent vision loss or blindness. In 2023, this provider wrote 16 Medicare prescriptions for Rocklatan, about half the volume of the typical Massachusetts prescriber of this medication (32). Medicare paid an average of $584.47 per fill, versus $546.46 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 22.7 30-Day Fills standardized to 30-day supplies 620 Days of Medication total across all patients in 2023 | |||
| Acetazolamide ErAcetazolamide | 14 | $175.89 | ≈ Typical |
About Acetazolamide Er: Acetazolamide is used to prevent and reduce the symptoms of altitude sickness. Show more ▾ This medication can decrease headache, tiredness, nausea, dizziness, and shortness of breath that can occur when you climb quickly to high altitudes (generally above 10,000 feet/3,048 meters). It is particularly useful in situations when you cannot make a slow ascent. The best ways to prevent altitude sickness are climbing slowly, stopping for 24 hours during the climb to allow the body to adjust to the new height, and taking it easy the first 1 to 2 days. This medication is also used with other medications to treat high pressure inside the eye due to certain types of glaucoma. Acetazolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. It works by decreasing the production of fluid inside the eye. It is also used to decrease a buildup of body fluids (edema) caused by heart failure or certain medications. Acetazolamide can work less well over time, so it is usually used only for a short period. It has also been used with other medications to treat certain types of seizures (petit mal and unlocalized seizures). One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337) In 2023, this provider wrote 14 Medicare prescriptions for Acetazolamide Er, about 78% of the volume of the typical Massachusetts prescriber of this medication (18). Medicare paid an average of $175.89 per fill, versus $91.61 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 18 30-Day Fills standardized to 30-day supplies 540 Days of Medication total across all patients in 2023 | |||
| RestasisCyclosporine | 14 | $1,008.96▼ below MA avg | ▼ Less than typical |
About Restasis: Cyclosporine eye drops are used to treat a certain type of dry eyes. Show more ▾ They work by increasing the amount of tears you make. A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. In 2023, this provider wrote 14 Medicare prescriptions for Restasis, about a quarter of the volume of the typical Massachusetts prescriber of this medication (52). Medicare paid an average of $1,008.96 per fill, versus $1,116.33 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 20 30-Day Fills standardized to 30-day supplies 600 Days of Medication total across all patients in 2023 | |||
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 13 | $250.87▼ below MA avg | ▼ Less than typical |
About Brimonidine Tartrate-Timolol: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients. In 2023, this provider wrote 13 Medicare prescriptions for Brimonidine Tartrate-Timolol, about 62% of the volume of the typical Massachusetts prescriber of this medication (21). Medicare paid an average of $250.87 per fill, versus $296.64 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 26.5 30-Day Fills standardized to 30-day supplies 775 Days of Medication total across all patients in 2023 | |||
| CombiganBrimonidine Tartrate/Timolol | 12 | $372.26▼ below MA avg | ▼ Less than typical |
About Combigan: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients. In 2023, this provider wrote 12 Medicare prescriptions for Combigan, about a third of the volume of the typical Massachusetts prescriber of this medication (39). Medicare paid an average of $372.26 per fill, versus $432.63 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 17.2 30-Day Fills standardized to 30-day supplies 515 Days of Medication total across all patients in 2023 | |||
| Acetazolamide | 12 | $157.56 | ▼ Less than typical |
About Acetazolamide: Acetazolamide is used to prevent and reduce the symptoms of altitude sickness. Show more ▾ This medication can decrease headache, tiredness, nausea, dizziness, and shortness of breath that can occur when you climb quickly to high altitudes (generally above 10,000 feet/3,048 meters). It is particularly useful in situations when you cannot make a slow ascent. The best ways to prevent altitude sickness are climbing slowly, stopping for 24 hours during the climb to allow the body to adjust to the new height, and taking it easy the first 1 to 2 days. This medication is also used with other medications to treat high pressure inside the eye due to certain types of glaucoma. Acetazolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. It works by decreasing the production of fluid inside the eye. It is also used to decrease a buildup of body fluids (edema) caused by heart failure or certain medications. Acetazolamide can work less well over time, so it is usually used only for a short period. It has also been used with other medications to treat certain types of seizures (petit mal and unlocalized seizures). One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337) In 2023, this provider wrote 12 Medicare prescriptions for Acetazolamide, about half the volume of the typical Massachusetts prescriber of this medication (24). Medicare paid an average of $157.56 per fill, versus $76.84 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 26 30-Day Fills standardized to 30-day supplies 734 Days of Medication total across all patients in 2023 | |||
| Brinzolamide | 11 | $388.28 | ▼ Less than typical |
About Brinzolamide: Brinzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 11 Medicare prescriptions for Brinzolamide, about a third of the volume of the typical Massachusetts prescriber of this medication (32). Medicare paid an average of $388.28 per fill, versus $352.06 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 17.9 30-Day Fills standardized to 30-day supplies 538 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for MILICA MARGETA M.D. PH.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Ophthalmology prescribing approach at this Boston, MA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among MA prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
